Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease.
about
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models.The Impact of Zonisamide on the Development and Course of Alcohol Dependence in Rabbits. A pharmaco-EEG study.
P2860
Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@en
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@nl
type
label
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@en
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@nl
prefLabel
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@en
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Zonisamide reduces nigrostriat ...... model of Parkinson's disease.
@en
P2093
Atsushi Nambu
Hiromi Sano
Miho Murata
P2860
P304
P356
10.1111/JNC.13116
P407
P577
2015-05-08T00:00:00Z